Dr. Ralph Benedict
Professor of Neurology and Psychiatry
University at Buffalo
New York, United States of America


Prof. Thomas Berger
Chair, Department of Neurology
Medical University of Vienna
Vienna, Austria

Prof. Thomas Berger, MD, MSc, is Chair of the Dept. of Neurology, Medical University of Vienna, Austria. He graduated in 1991 at the Faculty of Medicine, University of Vienna, Austria, and postgraduated in 2002 in “Hospital Management and Health Economics“. He started his career 1992 at the Dept. of Exp. Neuropathology and Neuroimmunology (Hans Lassmann) and was resident at the Dept. of Neurology, Faculty of Medicine, University of Vienna from 1993-1995. In 1995 he moved to the Dep. of Neurology, Medical Univ. of Innsbruck, where he continued his academic track (1998 board certification in neurology and psychiatry, habilitation in 2003 and Vice-Director of the Dept. opf Neurology from 2014-2018). In 2010 he was responsible for planning and implementation of the Clinical PhD programs at the Medical Univ. of Innsbruck and served as Clin PhD program director until 2018. Scientific interests focus on inflammatory demyelinating CNS disorders, especially in MS and NMO. He has published more than 270 peer-reviewed papers/research letters/invited reviews and several books/book chapters. He was several times awarded, including by ECTRIMS and by the European Charcot Foundation and was/is principal investigator in more than 70 clinical treatment trials. T. Berger is the National MS Coordinator of the Austrian Society of Neurology and member/chair of several international and national MS organizations and panels.

Prof. Nicola De Stefano
Associate Professor of Neurology
Department of Medicine, Surgery and Neuroscience, University of Siena
Sienna, Italy

Nicola De Stefano is Associate Professor of Neurology at the Department of Medicine, Surgery and Neuroscience, University of Siena, Italy. He is also Head of the NeuroImaging Laboratory in the same Department; Adjunct Professor, Montreal Neurological Institute, McGill University, Canada; and Honorary Visiting Professor, Imperial College London, UK.


Prof. De Stefano graduated with his MD degree from the University of Siena, Italy, and went on to undertake his internship. After successfully completing his residency in neurology, he went on to pursue postgraduate training overseas in Canada before returning to his alma mater where he obtained his PhD.


Prof. De Stefano’s current research interests lie in multiple sclerosis and other neurological diseases involving the brain white matter. In particular, he is a renowned expert on the clinical application of new neuroimaging techniques in brain and muscle of patients with neurological disease.


Prof. De Stefano is a member of several prestigious professional societies and organisations including the American Academy of Neurology, the European Neurological Society, the Italian Society of Neurology, and the International Society for Magnetic Resonance in Medicine. Since 2009, he has been co-chairing the MAGNIMS European network for the study of magnetic resonance in multiple sclerosis. He has delivered numerous invited lectures worldwide, and to date, he has published numerous books and book chapters ad well as more than 250 papers in prestigious international peer-review publications in the area of neurology and neurometabolic disorders. He is also currently serving as a reviewer for the most relevant international neurologic journals.

Dr. Fujihara Kazuo
Professor, Department of Multiple Sclerosis Therapeutics
Fukushima Medical University School of Medicine
Fukushima, Japan

Kazuo Fujihara, M.D.is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He is a member of the International Panel on Diagnosis of MS (the 2010 and 2017 revisions to the McDonald Criteria) and the International Panel on NMO Diagnosis (the 2015 International Consensus Diagnostic Criteria of NMOSD). Since 2013, he has served on the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF), and the Board of European Charcot Foundation (ECF). He is an inaugural member and President (2018~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), an honorary member of The Association of Sri Lankan Neurologists (Honorary Member, 2012~), Indian Academy of Neurology (Honorary Corresponding Member, 2015~) and Hong Kong Society of Multiple Sclerosis (Honorary Fellow, 2015~), an Editorial Board member of Neurology: Neuroimmunology and Neuroinflammation (2018~), and Associate Editor of Frontiers in Neurology (section Multiple Sclerosis and Neuroimmunology, 2017~).

Dr. Samia Khoury
Associate Dean, Clinical and Translational Research, Director of Abu Haidar Neuroscience Institute and Nehme and Therese Tohme Multiple Sclerosis Center
American University of Beirut Medical Center
Beirut, Lebanon

Dr. Khoury is currently the Associate Dean for Clinical and Translational Research at the American University of Beirut. Since October 2011, she has served as the Director of the Abu Haidar Neuroscience Institute, and the Director of the new AUBMC Multiple Sclerosis (MS) Center at AUBMC in Beirut, the first MS center in the region. She is a professor of neurology at the American University of Beirut. In 2007, Dr. Khoury was awarded the prestigious Kuwait Prize for Sciences by the Kuwait Foundation for the Advancement of Sciences for her work in immunology. She has published over 200 scholarly articles, reviews, and book chapters.

Dr. Yaser Al Malik
Assistant Professor & Consultant Neurologist
King Saud bin Abdulaziz University for Health Sciences
Riyadh, Saudi Arabia

Dr. Yaser Al Malik is an Assistant Professor of Neurology at college of medicine, King Saud bin Abdulaziz University for Health sciences, Riyadh, Saudi Arabia. He is also a consultant Neurologist at King Abdulaziz medical city in Riyadh.

Dr. Al Malik graduated from medical school at Qassim University in 2008. He completed his residency training in adult neurology at University of Calgary, Canada in 2014. After becoming a fellow of the Royal College of Physicians of Canada, he went on to complete a fellowship in Multiple Sclerosis and Neuroimmunology at University of Calgary (2014-2016), and then completed a second fellowship in clinical Neurophysiology (2016-2017). In addition, his interest in teaching has led him to pursuit a Master Degree in Medical Education.

Dr. Al Malik is involved in clinical research, including industry sponsored trials, quality assurance projects and registries. He is also involved in teaching of residents and medical students in various settings.

Dr. Saloua Mrabet
Assistant Professor, Department of Neurology
Razi Hospital
Tunis, Tunisia

Dr. Saloua Mrabet is a Tunisian neurologist living in Tunis and working in Razi Hospital. She is a assistant professor in the Department of Neurology of Razi Hospital and the faculty of medicine of Tunis-University of Tunis El Manar. She is specialized in Multiple Sclerosis and neuroinflammatory diseases, neuro-immunology and neuro-ophtalmology. She graduated in Neuro-ophthalmology since 2017 at the faculty of Pierre and Marie Curie Paris VI. She is working in the first Multiple Sclerosis Center in Tunisia since June 2018.

Dr. Raed Al Roughani
Consultant Neurologist, Director of MS Clinic
Amiri Hospital & Dasman Research Institute
Kuwait City, Kuwait

Dr. Raed Alroughani received his degree in medicine (MD) from Charles University. He underwent his neurology residency at the University of British Columbia and subsequently obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then completed a fellowship in demyelinating disorders at the University of British Columbia. He joined the division of neurology at Amiri hospital (Kuwait) as a consultant neurologist. He currently serves aas a head of MS clinic at Ibn-Sina hospital & Amiri Hospitals.

Dr Alroughani’s fields of interest are principally directed towards the epidemiology and therapeutics of multiple sclerosis. He established the national MS registry and multidisciplinary MS clinic in Kuwait. He is actively involved in research and he authored and co-authored more than 80 papers in the last 5 years. His major research interests are epidemiology and therapeutics.

He is currently the secretary general of MENACTRIMS (Middle East North Africa Committee for the Treatment and Research in Multiple Sclerosis). He is the vice president of the Scientific Leadership Group of MSBase Foundation and an executive board member of ParadigMS Foundation. He currently sits on the executive boards of various scientific associations, steering committees and advisory boards, mainly in the field of MS.

Prof. Mohammad Ali Sahraian
Professor of Neurology
Sina Hospital, Tehran University of Medical Sciences
Tehran, Iran

Dr. Sahraian graduated from Shiraz University of Medical Sciences (Shiraz-Iran). He undertook board of neurology and fellowship in medical education from Tehran University of Medical sciences. Dr. Sahraian had a training in multiple sclerosis at University hospital Basel (Switzerland). He is currently professor of clinical neurology and the director of MS research center in Tehran University of Medical Sciences and vice-chancellor for Iranian MS society.


He has served as an investigator on several clinical trials in neurology and has published more than 170 articles in peer-reviewed journals and presented abstracts on MS at international meetings. He has been invited to deliver several lectures on MR evaluations and disability assessment at different meetings on multiple sclerosis. He has published “MRI atlas of lesions in multiple sclerosis” and has been the author of “Multiple Sclerosis” chapter in Encyclopedia of Diagnostic Imaging. He is one of the authors of MRI Training CD-ROM which was translated into four languages. Dr. Sahraian areas of interests are management of multiple sclerosis and neuromyelitis optica.

Prof. Mike Wattjes
Consultant Neuroradiologist
Hannover Medical School
Amsterdam, Netherlands

After finishing his study of Medicine at Hannover Medical School in Germany, Dr. Wattjes started his internship in Neurology at the Department of Neurology, University Hospital Bonn, Germany in 2001. In 2002, he started his residency in Radiology at the Department of Radiology, University Hospital Bonn. During his residency he started his research activities in the field of high field MRI applications in Neuroradiology, particularly focusing in neuroinflammatory diseases such as multiple sclerosis. In 2007, he started a research fellowship at the MS and Alzheimer Center of the VU University Medical Center in Amsterdam supported by the Exchange Program of the European Society of Neuroradiology. Later he became a clinical fellow Neuroradiology and was appointed as a senior staff radiologist in 2009. In July 2017 he started his new senior staff position at Department of Neuroradiology at Hannover Medical School, Germany. He has been appointed as a Professor of Neuroradiology in February 2019. His primary research and clinical interest included neuroinflammatory and neurodegenerative diseases as well as neurooncology. He serves a reviewer for several high impact journals and for institutions including the Medical Reseach Council, UK, and the Federal Ministry of Research in Germany.

Prof. Bassem I. Yamout
Professor of Clinical Neurology, Director, Multiple Sclerosis Center Clinical Research
American University of Beirut Medical Center
Beirut, Lebanon

Bassem Yamout is currently Professor of Clinical Neurology at the American University of Beirut Medical Center. He graduated from the medical school at the American University of Beirut in 1984, received his training in neurology at the University of Cincinnati-Ohio followed by a fellowship at the Montreal Neurological Institute-McGill University. In 1988 he joined the faculty of the American University of Beirut. His main focus of research is in the field of multiple sclerosis. He is currently president of the MENACTRIMS, head of clinical research at the Multiple Sclerosis Center, fellow of the American Academy of Neurology, and member of multiple regional and international MS advisory boards.


Dr. Yamout is one of the leading experts on multiple sclerosis in the Middle East and Arab region with recent research on epidemiology of the disease in the region, quality of life of patients in the Middle East, novel therapies such as stem cell transplantation and venous stenosis, and the impact of wars on the course of multiple sclerosis. In addition he is currently the principal investigator on several ongoing international multiple sclerosis research trials. Dr Yamout has authored many research and review papers and is currently Chief Editor of the MS newsletter “MS today”, and on the editorial board of “Multiple Sclerosis and Related Disorders”.

Prof. Tarek Yousry
Professor of Neuroradiology
University College London, Institute of Neurology
London, United Kingdom

Professor Tarek Yousry is head of the Neuroradiological Academic Unit and head of the Division of Neuroradiology and Neurophysics at UCL Institute of Neurology as well as head of Lysholm Department of Neuroradiology at National Hospital for Neurology & Neurosurgery in London. Professor Yousry started his medical education at Cairo University. Having received a scholarship, he continued his medical education at the Ludwig-Maximillans-Universität (LMU) in Germany and graduated in 1984. This was also where he completed his training in radiology and neuroradiology. In 1997 he obtained his doctorate in medicine for his work on “Functional Imaging”, and was appointed as professor of neuroradiology and head of Lysholm Department of Neuroradiology in 2001 in London. His interest focuses on establishing MR based outcome measures of various CNS and neuromuscular diseases by defining their histological basis at 9.4T and applying them at 1.5T, 3T and 7T, and on improving treatment outcome through precise identification of anatomical structures. He has published in the areas of MR anatomy, multiple sclerosis, movement disorders, prion diseases (CJD), and stroke and neuromuscular diseases.

Ms. Rola Fareed Alarieh
MS Nurse Specialist
King Fahad Medical City
Riyadh, Kingdom of Saudi Arabia

Mrs. Rola Fareed Alarieh is a Multiple Sclerosis Program Clinical Nurse Specialist/Coordinator at the King Fahad Medical City in Riyadh, Saudi Arabia. She obtained her B.Sc. degree in Nursing in the year 2000 at Jordan University in Amman, and completed her master’s degree in 2014 at Hashemite University in Zarqa’a. She started her career as a NICU Registered Nurse in Jordan and from then on became a Pediatric Clinical Instructor in Saudi Arabia. She was appointed as a Clinical Nurse Coordinator of the Ketogenic Diet Therapy and Pediatric Epilepsy Program at the National Neuroscience Institute of King Fahad Medical City in 2015 before she eventually achieved her current position. Mrs. Alarieh is also a BLS Instructor at the American Heart Association.


She developed a comprehensive clinical program for MS and Ketogenic Diet Therapy, and is involved in handling various projects at King Fahad Medical City. Her professional memberships include Nurses and Midwifes Council, Amman-Jordan and Saudi Commission for Health Specialties.

Prof. Frederik Barkhof
Professor of Neuroradiology
University College London
London, United Kingdom

Prof. dr. Frederik Barkhof received his MD from VU University, Amsterdam in 1988 and defended his PhD thesis in 1992, for which he received the Philips Prize for Radiology (1992) and the Lucien Appel Prize for Neuroradiology (1994). Since 2001 he serves as a full Professor in Neuroradiology at the department of Radiology & Nuclear Medicine at VUmc. He is a senior staff member of the MS Center Amsterdam, and senior consultant of the Alzheimer Center, VUmc. In 2015 he was appointed as full Professor of Neuroradiology at institutes of Biomedical Engineering and Neurology at UCL in London (UK) to translate novel imaging techniques. Prof. Barkhof was the chairman of the Dutch Society of Neuroradiology and the MAGNIMS study group for many years. He is project leader of AMYPAD (www.amypad.eu) and head of the imaging scientific advisory groups of EPAD (www.ep-ad.org). He serves on the Editorial boards of Radiology, Brain, Multiple Sclerosis Journal, Neuroradiology and Neurology. He (co)authored >800 papers referenced in PubMed, has an H-factor of 95 and is listed among 3000 most influential scientists world-wide by Thompson-Reuters.

Dr. Smail Daoudi
Consultant Neurologist and Head of Neurology Department
Nedir Mohammed Teaching Hospital
Tizi-ouzou, Algeria

Prof. Smail Daoudi is Associate Professor of neurology and head of the Neurology Department since 2006 at Nedir Mohammed Teaching Hospital in Tizi-ouzou located in north center of Algeria. After completing his medical residency in the capital Algiers, he held a position for a Fellowship Program at Pitie Salpetriere Teaching Hospital in Paris and after in Haute Pierre Teaching Hospital in Strasbourg, France. From that experience he shown a research interest for inflammatory CNS diseases, particularly for Multiple sclerosis and has authored many articles.
He has developed a multidisciplinary unit specialized in the management of multiple sclerosis for a total of 1300 patients until today.


In addition, he is part of several panels experts at the regional and international level, in particular for the management of pain and since this year he is a member of the Applied Research Committee of the WFN.

Prof. Gavin Giovannoni
Professor of Neurology
Blizard Institute, Barts and The London School of Medicine and Dentistry
London, United Kingdom

Gavin Giovannoni was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London and the Department of Neurology, Barts Health NHS Trust in November 2006. In September 2008 he took over as the Neuroscience Centre Lead in the Blizard Institute. Gavin did his undergraduate medical training at the University of the Witwatersrand, South Africa, where he graduated in 1987. He moved to the Institute of Neurology, Queen Square, London in 1993 after completing his specialist training in neurology in South Africa. After three years as a clinical research fellow, under Professor Ed Thompson, and then two years as the Scarfe Lecturer, working for Professor W. Ian McDonald, he was awarded a PhD in immunology from the University of London in 1998. He was appointed as a Clinical Senior Lecturer, Royal Free and University College Medical School, in 1998 and moved back to Institute of Neurology, Queen Square in 1999. He was promoted to Reader in Neuroimmunology in 2004. His clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. He is particularly interested in clinical issues related to optimising MS disease modifying therapies. His current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, defining the “multiple sclerosis endophenotype”, multiple sclerosis related neurodegeneration, multiple sclerosis biomarker discovery, multiple sclerosis clinical outcomes and immune tolerance strategies. His team focus on translational research and therefore have an active clinical trial programme.

Mr. Abdelfatah Ibrahim
Capacity Building Manager
MS International Federation
London, United Kingdom

Abdelfatah is a Capacity Building Manager at the MS International Federation (MSIF), a unique global network of over 100 organisations, people affected by MS, volunteers and staff from around the world.

Abdel focuses on the MENA and Pan Asia regions, working with MS organisations, their staff and volunteers, encouraging them to exceed their potential and supporting them to improve the quality of life of people with and affected by MS in their countries.

Abdel has a Master’s degree in International Development (Poverty, Inequality and Development). He has nine years’ experience in the international development and civil society sectors. He is a specialist in organisational development with experience of managing projects in health, education and poverty reduction in MENA and Africa. Prior joining MSIF in 2012, Abdel worked for number of international aid agencies.

2017 marks 50 years of the global MSIF movement and the start of a new strategy with five ambitious aims; improving scientific understanding and treatments, improving access to treatment, supporting informed decision making, advocating for change and strengthening the global movement.

Dr. Jaber Al Khaboori
Consultant Neurologist, Head of Neurology Department
Royal Hospital
Muscat, Oman

Jaber Al Khaboori, Senior Consultant Neurologist comes with 24 years of rich experience in the practice of neurology in various countries including UK, Egypt, Ireland, London, Italy, Austria, Lebanon, Jeddah, Qatar, Copenhagen, Oman etc. He has extensive experience in the management of patients with stroke, epilepsy, neurological complications of diabetes, peripheral neuritis, facial palsy, multiple sclerosis, Parkinson’s and Alzheimer’s Disease. He currently holds the position of Head of Departmentof Neurology, Royal Hospital. Muscat, Oman.

Dr. Emmanuelle Leray
Assistant Professor in Epidemiology
EHESP National French School of Public Health
Rennes, France

Dr. Emanuelle Leray is an assistant professor in epidemiology in the national school of public health in France.
She is strongly involved in research in multiple sclerosis for many years. Her fields of interest are: natural history studies, disability progression, survival, safety and effectiveness of disease-modifying therapies and access to health care providers.


She mainly uses two data sources: first, clinical data collected by neurologists in the EDMUS database, at local level (Rennes, with Pr Edan) and at national level through the OFSEP registry (coordinated in Lyon, by Pr Vukusic); and second, the national health insurance database which covers 97% of the French population and contains exhaustive data regarding use of health care resources.

Dr. Suzan Noori
Consultant Neurologist, Assistant Professor of Neurology
University Hospital Sharjah
Sharjah, United Arab Emirates

Dr. Suzan Noori is a Senior Consultant Neurologist at University Hospital Sharjah (UHS) & Assistant Professor at the Medical College of University of Sharjah. She obtained her MBBS and her Clinical MD in Medicine from the University of Khartoum. She is a fellow of the Royal College of Physician of Edinburgh (FRCP Edn.); & Member of American Academy of Neurology (MAAN). Dr. Noori holds conjoint academic responsibilities in the Medical College – University of Sharjah, and is an active member in the research group at the university. She also has obtained her post graduate degree in the management of multiple sclerosis from Leeds Metropolitan University.

Her key professional skills and activities include: Botulinum toxin Injections for chronic migraine & Therapeutic Botox for Dystonia and treatment of Spasticity), Intrathecal Baclofen pump refilling and programming for treatment of spasticity. She is a pioneer in using Botox for chronic migraine in UAE. She runs Botox training workshops locally & regionally.

Dr. Noori is a member of many professional bodies locally; regionally and internationally as well as a member of many quality committees and task forces. She is one of the main founders, and currently; the head of the scientific committee of UAE MS support group. She has been actively involved in different meetings & forums as well as in the media and had coordinated regular campaigns for raising awareness for MS in her community.

Dr. Maria Assunta Rocca
Head, Neuroimaging of CNS White Matter Unit
Hospital San Raffaele
Milan, Italy

Dr. Rocca is currently Head of the “Neuroimaging of CNS White Matter Unit”, Department of Neurology, Institute of Experimental Neurology, Scientific Institute Ospedale San Raffaele, Milan, Italy.


Her activity is mainly focused on the application of structural and functional MR based techniques to improve the understanding of central nervous system function and dysfunction in healthy individuals and diseased people, particularly patients with MS and other white matter disorders. Dr. Rocca is currently conducting and coordinating several national and international projects in adult and pediatric populations.


She is member of various national and international Scientific Societies and, in some of them, she covered or is covering institutional roles (MAGNIMS, Neuroimaging Study Group of the Italian Neurological Society, International Pediatric Multiple Sclerosis Study Group, European Academy of Neurology). She coordinated the MRI acquisition and analysis of several large-scale international MRI-monitored trials of MS.


Dr. Rocca is author or co-author of more than 430 papers published on peer-reviewed journals and of 52 book chapters. She is also reviewer of several international scientific journals and for many Governmental Organizations and private Foundations. Due to her scientific activity she participated, as a speaker and/or chairman, to more than 370 international congresses and she received several national and international Awards.


In 2013, Dr. Rocca was awarded the “Rita Levi Montalcini” Prize for her outstanding contributions to the study of MS.
Dr. Rocca is Non-Tenured Professor at Università Vita-Salute San Raffaele, Milan.
In 2017, she received the qualification as Full Professor of Neurology in Italy.

Prof. Hatem Shehata
Professor of Neurology
Cairo University
Cairo, Egypt

Hatem S Shehata, MD is a Professor of Neurology at Cairo University, Egypt. He received his Master in Neuropsychiatry in 1997, and after receiving Medical Degree in Neurology from Cairo University, Egypt in 2001; he has completed several internships in neurorehab in Milan-Italy, Heywood Hospital Stoke-On-Trent, Staffordshire-UK and Danish headache center, Glostrup Hospital-Denmark.
He is officially appointed to the broad of directors of MScare-Egypt, a member of MSIF since 2016, and he has actively participated in all patients education forums since 2007.


His current research is focused on multiple sclerosis related epidemiological measures, integrative rehab program of different neurological disabilities and headache research surveys.


Dr. Shehata is author or co-author of many articles published on peer-reviewed journals and he is also reviewer of several international scientific journals. He participated, as a ‘speaker’ to international congresses including WCN, AAN, ECTRIMS, and he shared as speaker/poster presenter/chairman in all CNC
meetings held in Egypt since 2002 till now.

Dr. Maria Pia Sormani
Professor of Biostatistics
University of Genoa
Genoa, Italy

Maria Pia Sormani, PhD is Professor of Biostatistics at the University of Genoa, Italy. She received her Master in Medical Biostatistics at the University of Milan, her Master in Medical Physics at the University of Pisa, and her degree in Bio-Physics at the University of Genoa in Italy. She has a background in Oncology, but her main field of Research is in Multiple Sclerosis: she collaborated for more than ten years with the Neuroimaging Research Unit at the San Raffaele Hospital in Milan, studying the methodological issues related to the use of Magnetic Resonance Imaging in Multiple Sclerosis. She is now faculty member at the University of Genoa, where she teaches Biostatistics and Research Methods to students in medicine. She serves on the US Multiple Sclerosis National Society Clinical Trials Advisory Committee, in the Multiple Sclerosis Outcome Assessment Consortium (MSOAC), is in the Editorial Board of Multiple Sclerosis Journal and she published more than 330 papers on peer reviewed journals, mostly on MS, has an h-index=64 and an IF>1500.

Dr. Anthony Traboulsee
Professor of Neurology
University of British Columbia
Vancouver, Canada

Anthony Traboulsee is a Professor of Neurology and Research Chair of the MS Society of Canada at the University of British Columbia in Vancouver, Canada. He is the Head of the MS and NMO Program at UBC Hospital. He is a neurologist with a research focus the development of practice guidelines for the use of MRI in the management of MS, establishing advanced MRI imaging tools for monitoring remyelination in Multiple Sclerosis, and the treatment of Neuromyelitis Optica. He was the lead author on Consortium of MS Centers international MRI guidelines for diagnosis and treatment of MS and co-author on the International Panel Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorder and the International Panel Diagnostic Criteria for Multiple Sclerosis.


He has been the principal investigator for over 30 clinical trials at UBC. He is a member of the Brain Health in MS international policy report (www.msbrainhealth.org). His overarching treatment philosophy for relapsing MS is to engage patients in personalized treatment goals as early as possible, to use the most effective and safest therapies available, especially during the critical first decade of the disease.

Dr. Helen Tremlett
Professor and Canada Research Chair
Faculty of Medicine, University of British Columbia
Vancouver, Canada

Canada Research Chair in Neuroepidemiology and Multiple Sclerosis and Professor at the University of British Columbia, Vancouver, Canada in the Faculty of Medicine, Division of Neurology. Her research program is also funded through operating grants from the Canadian Institutes of Health Research (CIHR), the MS Society of Canada, the MS Scientific Research Foundation, the US National MS Society among others. Trained in pharmacoepidemiology and multiple sclerosis with a PhD from Cardiff University, UK. Heads the Tremlett Lab and the Epidemiology in Multiple Sclerosis research program. Research interests include: the natural history of MS; prognosis and predictors of disease progression in MS; mortality; safety and effectiveness of the immunomodulatory drugs (IMDs) for MS; pharmacogenomics; MS epidemiology; incidence and prevalence of MS; life expectancy in MS; comorbidities and MS; pregnancy and MS; impact of parental MS on childhood developmental outcomes; health administrative data; the MS prodrome; the gut microbiome and MS.

Prof. Magd Zakaria
Professor of Neurology
Ain Shams University
Cairo, Egypt

Dr. Magd Zakaria was born in Cairo, 26 October 1956. Dr. Zakaria attended the English School of Cairo till graduation in 1974. He was a student of the Medical School of Ain Shams University till 1980 where he graduated with honors. Dr. Zakaria completed his residency at the Neuropsychiatric Department of Ain Shams University till 1984. He obtained his Master’s Degree in Neuropsychiatry. He became Assistant Lecturer in 1989 and then after obtaining his MD degree in Neurology in 1989. Dr. Zakaria became Assistant Professor of Neurology in 1994 and Professor of Neurology since 1999 until now. He was Head of the Neurology Department at the Ain Shams Specialized University Hospital in 1990 and Head of the Stroke Unit in 1991. Since 2014, Dr. Zakaria has become the Head of the Multiple Sclerosis Unit at the Ain Shams Specialized University Hospital.


Dr. Zakaria is currently the President of the Egyptian Society of Multiple Sclerosis and a member of the editorial board of the journal MSARD (Multiple Sclerosis and Related Disorders). He is also a member of the MENACTRIMS assembly board and Egypt’s Brain Health Champion (MS Brain Health Organization.


He was also the head of the Neuropsychiatric Department of the Ain Shams medical school from August 2015 till July 2017.


In, January 2018 he became a member of the International Medical and Scientific Board ( IMSB) of the Multiple Sclerosis International Federation ( MSIF ).

Dr. Brenda Banwell
Chief, Division of Neurology
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, United States of America

Dr. Banwell currently serves as the Chief of Child Neurology and Professor of Neurology and Pediatrics at The Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Dr. Banwell’s clinical and research focus is in the area of pediatric multiple sclerosis and she leads a 24 site North American prospective study of clinical outcomes, genetics, immunology and neuroimaging features of MS in children. Dr. Banwell also serves as the Research Chair of the International Pediatric Multiple Sclerosis Study Group.


Dr. Banwell studied medicine at the University of Western Ontario, followed by residencies in Pediatrics at the University of Western Ontario and Child Neurology at the University of Toronto. She then pursued a Neuromuscular Fellowship at the Mayo Clinic, Rochester, Minnesota. Dr. Banwell was appointed as an Assistant Professor of Pediatrics and Neurology at The Hospital for Sick Children, University of Toronto in 1999, and rose to the rank of Full Professor at the University of Toronto prior to relocating to The Children’s Hospital of Philadelphia in 2012. Dr. Banwell remains as Adjunct Senior Scientist in the Research Institute at The Hospital for Sick Children.

Prof. Helmut Butzkueven
Professor and Chair, MS and Neuroimmunology, Director, MS Service, Head, MS and Neuroimmunology Service
Monash University, Eastern Health and Alfred Health
Melbourne, Australia

Professor Helmut Butzkueven (MBBS 1992, PhD 2002), is an academic neurologist specializing in management of Multiple Sclerosis (MS) and real-world MS outcomes research.


He is the Chair of MS and Neuroimmunology Research at the Central Clinical School, Monash University and Head of MS and Neuroimmunology services at Alfred Helath and Eastern Health. Helmut Butzkueven is the Managing Director of the MSBase Foundation (www.msbase.org), a global online MS cohort study which commenced in 2004, with more than 60,000 patients enrolled from 117 centres to date.


His overarching research theme and clinical interest is the use of registry data, MRI data, cognitive testing, genomis and patient self-monitoring data to evaluate treatment strategies to optimize benefit and safety of MS therapies.

Ms. June Halper
Chief Executive Officer (CEO)
Consortium of Multiple Sclerosis Centers (CMSC), International Organization of MS Nurses, Multiple Sclerosis Nurses International Certification Board
New York, United States of America

June Halper is a certified adult nurse practitioner who has specialized in multiple sclerosis since 1978. She is the Chief Executive Officer of the Consortium of Multiple Sclerosis Centers (CMSC) and Executive Director of the IOMSN.


Ms. Halper has published and lectured extensively on multiple sclerosis and its ramifications. Her numerous publications include Comprehensive Nursing Care in Multiple Sclerosis and Advanced Concepts in Nursing Care in Multiple Sclerosis, co-editor of Staying Well with Multiple Sclerosis: A Self-Care Guide, and co-editor of Nursing Practices in Multiple Sclerosis: A Core Curriculum. She is a member of the American Academy of Nurse Practitioners, the founding director of IOMSN, the International Organization of MS Nurses, and the recipient of the IOMSN’s first June Halper Award for Excellence in Nursing in Multiple Sclerosis. She was inducted as a Fellow into the American Academy of Nursing in November 1999. In 2000, she spearheaded the establishment of the Multiple Sclerosis International Credentialing Board who developed the first international certification examination in multiple sclerosis nursing offered in June 2002 and bi-annually thereafter. As CEO of the CMSC, she initiated the first certification examination for MS specialists in 2004.
As early as 1995, Ms. Halper was involved in the development of clinical practice guidelines in multiple sclerosis which were multi-organization collaborative projects. She was involved in the publication of guidelines in bladder dysfunction in MS, fatigue in MS, spasticity in MS, immunizations in MS, and disease modification in MS. Subsequently the CMSC has adopted a best practices model and Ms. Halper was involved in publication of models of comprehensive care, complex symptomatic management, and cognition to name a few publications. (please visit www.mscare.org for a full listing)


The NARCOMS and NARCRMS patient registries were established under Ms. Halper’s leadership and support. Both are have become sources of information about epidemiologic information about multiple sclerosis.

Dr. Jihad Inshasi
Consultant Neurologist
Rashid Hospital
Dubai, United Arab Emirates

Dr. Jihad Inshasi is a Professor of Neurology at Dubai Medical College (DMC/DHA). He is a Fellow of the American Academy of Neurology (FAAN). Dr. Inshasi developed and directs the MS Clinic and has established the Dystonia Clinic at Rashid Hospital (DHA).

Dr. Jihad is the Head of the Scientific Committee and a Founding and Board Member of the Emirates Neurology Society (EMINS/EMA). With the EMINS board members, he organized many Neurology meetings especially in the field of MS. Dr. Inshasi is a founding member and Ex-President of the Emirates League Against Epilepsy (ILAE).

Dr. Jihad is the author and/or co-author of many scientific papers published in peer-reviewed journals. He participated as the Principle/Leading Investigator in many phase 2, 3 & 4 drug trials and conducted many research projects particularly in the field of multiple sclerosis. Dr. Inshasi is a member of many local, regional and international associations/societies and advisory boards committees.

Dr. Mona Al Khawajah
Consultant Neurologist, Assistant Professor
King Faisal Specialist Hospital & Research Center, Al Faisal University
Riyadh, Kingdom of Saudi Arabia

Dr. Mona Alkhawajah is currently a Consultant Neurologist at the Neurosciences Department of King Faisal Specialist Hospital and Research Center, Riyadh (KFSHRC-R). She is also the Program Director of the Neurology Residency Training Program at KFSHRC-R and an Assistant Professor at Al Faisal University.


Dr. Mona Alkhawajah received her Medical Degree from King Saud University, Riyadh. She then pursued her residency training in Neurology at KFSHRC-R. After obtaining her Saudi Board in Neurology, she completed her Fellowship in Neuroimmunology at the University of British Columbia, in Vancouver, Canada. That was followed by a shorter fellowship in Neuromuscular Diseases at Vancouver General Hospital.


Dr. Alkhawajah is currently conducting several research projects in the field of MS. She has established the first Multiple Sclerosis support group in the Kingdom, the first meeting took place in June 2014. She is the organizer of the first (2015) and second (2017) walk for MS in Saudi Arabia, and is actively involved in educating the public about MS.

Ms. Joelle Massouh
MS Nurse Specialist
American University of Beirut Medical Center
Beirut, Lebanon

Ms. Massouh is currently the senior Multiple Sclerosis nurse at the Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center (AUBMC), in Beirut, Lebanon. She received her Bachelor of Science in Nursing from the American University of Beirut in 2007 along with a minor in Psychology. Ms. Massouh was awarded the Henriette Sabra Women’s Auxiliary Award for academic achievement, professional integrity, and contribution to professional and university life. She is a member of the Lebanese Order of Nurses since 2007 and a member of the Chi Iota Chapter of the Sigma Theta Tau International (STTI) Honor Society of Nursing. As part of her clinical training, she has worked with various populations of patients across the health-illness continuum. Ms. Massouh’s professional experience includes working with adult patients suffering from diverse neurological disorders including Multiple Sclerosis at AUBMC.


She joined the AUBMC MS Center since its inauguration and has since dedicated her professional experience to working exclusively with MS patients. She is certified in administering chemotherapy, and she is a member of the International Organization of Multiple Sclerosis Nurses (IOMSN). Ms. Massouh is the first nurse and healthcare professional in the Middle East to be double certified as a Multiple Sclerosis Certified Nurse (MSCN) by the Multiple Sclerosis Nursing International Certification Board (MSNICB), and as a Multiple Sclerosis Certified Specialist (MSCS) by the Consortium of Multiple Sclerosis Centers (CMSC). She has attended several national and international conferences and workshops in the field of MS. She has also presented many talks, specifically on MS nursing, to nurses, healthcare professionals, and patients at various national and regional congresses and training workshops. Ms. Massouh frequently participates in activities and campaigns aimed at promoting awareness on MS in the community. She is currently pursuing a Master of Science in Nursing, focusing on Neurology with a clinical interest in the Multiple Sclerosis patient population. This year she was invited to become an international delegate/board member representing the Middle East on the MSNICB, which was established by the IOMSN to develop criteria for certification and re-certification and administer the Certification Examination for Multiple Sclerosis Nurses.

Prof. Peter Rieckmann
Professor of Neurology, Head and Chair, Department of Neurology, Medical Director
Medical Park Loipl
Bamberg, Germany

Dr. Peter Rieckmann received his MD from the University of Göttingen in 1998. After a postdoctoral fellowship in Molecular Immunology at the NIH, Bethesda, USA, he completed his training in Neurology at the National Institute for Nervous Disease, London, UK and the University of Göttingen, Germany. He was Head of the Clinical Research Group for Multiple Sclerosis and Neuroimmunology at the Julius-Maximilians University of Würzburg and holds several positions as visiting Professor across the globe. In 2000, Professor Rieckmann became the MS Society of Canada Research Chair and Director of the MS Program at the University of British Columbia and Vancouver Hospital, Canada.


Dr. Reickmann’s major research interests are disease-modifying factors and regeneration in MS as well as functional aspects of the blood brain barrier in neuroimmunological diseases. Professor Rieckmann’s clinical goals include enhancing awareness and education about MS, developing effective and properly resourced services for MS outpatient care, and providing more customized treatments for patients. He is chairman of the MS in the 21st century steering group, an international MS stakeholder initiative. He serves on steering committees of various international multicenter MS trials (Phase II and III). Professor Rieckmann is a Fellow of the Royal College of Physicians and Surgeons, Canada and has over 200 papers to his credit in peer-reviewed medical journals.

Dr. Jameelah Saeedi
Professor of Neurology
King Fahad Medical City
Riyadh, Kingdom of Saudi Arabia

Dr. Jameelah Saeedi is a certified Saudi Neurologist who specializes in Multiple Sclerosis and Neuroimmunological Diseases. She received her medical qualification from King Abdulaziz University in Saudi Arabia in 2001 followed by two-boards in Neurology from Saudi Commission For Health Specialties and the Jordanian Medical Council in 2007. Dr. Saeedi is alumni of University of British Columbia where she pursued her fellowship and training in Neuroimmunology and Multiple Sclerosis with Prof. Peter Rieckman in 2009. In 2010 she received two more fellowships in Electromyography and Boutlinum Toxin Injection treatment from the University of Toronto and in 2011 she underwent intensive training in Single Fiber EMG in the Clinical Neurophysiology Department of Istanbul University. She also, spent sometime in the Neuroimmunology Laboratory of Oxford University of London with Prof. Angela Vincent in 2011.

She is one of few leading pioneers who holds vast knowledge, experience, sub-specializes and practices Multiple Sclerosis and Neuroimmunological Diseases in Saudi Arabia. She has been and still working at King Fahad Medical City as a Subspecialty Consultant and KFMC Comprehensive Neuroimmunology Program Director since July 2011.

Dr. Ahmed Shatila
Consultant Neurologist
Mafraq Hospital
Abu Dhabi, United Arab Emirates

Ahmed Osman Shatila obtained his BSc in Biology from the Wayne State University in the United States. He continued his medical education from the Medical College of Wayne State University from where he also conducted his Residency in Neurology and his Fellowship in Neurophysiology from.

Dr. Shatila’s interest’s include inpatient Neurology including, but not limited to Stroke, IV TPA program development, Status Epilepticus. He is also interested in helping facilities to develop a Neuro Hospitalist model where the inpatient care can develop independently from the outpatient services. This includes a combination of patients, resident and nursing education, inpatient consulting services and inpatient neurology services.

Dr. Eslam Shosha
Director, Multiple Sclerosis and NMO Clinic, Assistant Professor of Neurology
King Khaled Hospital, College of Medicine, Majmaah University-Riyadh
Riyadh, Kingdom of Saudi Arabia

Dr. Shosha is an Assistant Professor of Neurology and Director of Multiple Sclerosis and NMO clinic at King Khaled Hospital, college of Medicine, Majmaah University, Riyadh, Saudi Arabia. He did his Neurology residency training at king Faisal Specialist Hospital and Research Centre in Riyadh. Thereafter, he did two years of Clinical & Research Fellowship at The Mayo Clinic, USA and University of British Columbia hospital, Canada. The fellowship was in Neuroimmunology, Multiple Sclerosis and NMO. He published and participated in different projects in MS and NMO field. Dr. Shosha is also Fellow of The European Board of Neurology.

Dr. Mar Tintore
Consultant Neurologist
University Hospital Vall d’Hebron
Barcelona, Spain

Mar Tintoré, MD, PhD, serves as the clinical Coordinator of neurology in the Neurology-Neuroimmunology Department at the Multiple Sclerosis (MS) Centre of Catalonia (Cemcat) at the Hospital Vall d’Hebron in Barcelona, Spain. The Cemcat conducts clinical and basic research on MS and neuroimmunology to aid people living with MS. Dr. Tintoré serves on the Clinical Ethics Committee of the Vall d’Hebron University Hospital.


Dr. Tintoré received her medical degree and PhD from the Universitat Autònoma in Barcelona. Her PhD thesis was on endothelial cell antiendothelial antibodies in patients with MS. She completed her neurology residency at the University Hospital Vall d’Hebron and served as a deputy emergency physician at Vall d’Hebron University General Hospital in Barcelona.


Dr. Tintoré’s research interests include the initial presentation of demyelinating events, prognostic factors, pediatric MS, the gender aspects of MS, and treatment of the disease. Dr. Tintoré has authored or co-authored over 200 articles in peer-reviewed journals and has an h-index of 44. She is editor for Multiple Sclerosis Journal – Experimental, Translational and Clinical and member of the Executive Committee of ECTRIMS.

Dr. Bruce Trapp
Chair, Department of Neurosciences
Lerner Research Institute, Cleveland Clinic
Cleveland, Ohio, United States of America

Dr. Bruce Trapp is Chairman of the Department of Neurosciences at the Lerner Research Institute, Cleveland Clinic. He holds The Morris R. and Ruth V. Graham Endowed Chair in Biomedical Research.


Dr. Trapp received his Ph.D. from the Loyola University Stritch School of Medicine and postdoctoral training at the National Institutes of Health. He then became an Assistant Professor and subsequently an Associate Professor of Neurology at the Johns Hopkins University School of Medicine. He joined the Cleveland Clinic as Chairman of the Department of Neurosciences in 1994.


He holds multi-year grants from various agencies, including the NIH and the State of Ohio, and he has received numerous awards recognizing his work. He is also a Fellow of the AAAS. His research investigates the cause of neurological disability in multiple sclerosis patients, cellular mechanisms of brain repair in neurodegenerative diseases, the molecular biology of myelination, and mechanisms of glial neuroprotection. He has published over 240 peer-reviewed articles and over 40 book chapters.

Dr. Rumaiza Alyafeai
Consultant Neurologist/Neuroimmunolgist & MS Specialist
MY Clinic
Jeddah, Kingdom of Saudi Arabia

Currently working as a consultant neurologist and multiple sclerosis specialist at MY CLINIC Medical Center in Jeddah, Saudi Arabia. Has a Bachelor degree in Medicine and Surgery from University of Science & Technology Sana’a, Republic of Yemen in 2005. Finished a year of internship at King Abdulaziz University Hospital Jeddah, Saudi Arabia in 2007. Trained in the Neurology Saudi Board and became a certified Neurologist in 2012. Worked as an Assistant Consultant Neurologist in King Faisal Specialist Hospital Jeddah, Saudi Arabia till 2015. Certified on the European Board of Neurology in 2014. Former MSIF Alumni as a winner of McDonald’s Fellowship Grant & spent two years training at the Multiple Sclerosis Center of Catalonia in Barcelona, Spain 2017. Public speaker in media, including local TV and social media. Running local awareness days in multiple aspects of neurological conditions such as MS, strokes and epilepsy since 2009.

Dr. Maya Zeineddine
Pharmacist, MS Specialist
American University of Beirut Medical Center
Beirut, Lebanon

Dr. Zeineddine is currently the Clinical Pharmacist of the Nehme and Therese Tohme Multiple Sclerosis Center at the American University of Beirut Medical Center (AUBMC). She graduated from the School of Pharmacy at the Lebanese American University (LAU) in 2010, passed the colloquium exam and joined the Lebanese Order of Pharmacists in August 2010. Then, she was selected by LAU for the Doctor of Pharmacy program and was appointed in 2011 to do her clinical and ambulatory care rotations at Henry Ford Hospital and Karmanos Cancer Center, Detroit, Michigan. In June 2011, she completed her Doctor of Pharmacy program with distinction. Winner of the “Best Clinician” and “Positive Attitude” awards in 2011, she has completed several internships at major hospital and community pharmacies in Lebanon and the US. In August 2015, she successfully passed the Multiple Sclerosis Specialization examination and became the first Multiple Sclerosis Certified Pharmacist in Lebanon and the Middle East.


Dr. Zeineddine is involved in several clinical trials, especially in the field of multiple sclerosis. She has ongoing and completed clinical research projects on teriflunomide in pediatrics, the use of fingolimod in clinical practice, the safety of fingolimod in pregnancy, the rate of anti-JCV virus antibody seroconversion in the Middle East, and the safety and efficacy of reduced fingolimod dosage treatment. She is a member of several national and international professional organizations including the American College of Clinical Pharmacy, the National Multiple Sclerosis Society of Lebanon, the National Multiple Sclerosis Society, and the Multiple Sclerosis Association of America. In December 2015, she was appointed as Executive Secretary of the Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS).